Sichenzia Ross Friedman Ference LLP Advises Ladenburg Thalmann & Co. Inc. on $1 Million Secondary Public Offering for Arca Biopharma, Inc.
NEW YORK, August 2, 2012 (GLOBE NEWSWIRE) — New York- based securities law firm Sichenzia Ross Friedman Ference LLP announced that it has represented Ladenburg Thalmann & Co. Inc., as sole Placement Agent in a $1 million secondary public offering for Arca Biopharma, Inc. (“ARCA” NASDAQ). The registered direct offering was pursuant to a prospectus supplement to an effective S-3 registration statement. The offering consisted of 2,436,599 shares of common stock at an offering price of $0.391 per share and warrants to purchase 1,827,449 shares of common stock. The Sichenzia Ross team was led by partners Gregory Sichenzia and Marcelle Balcombe and associate Jeff Cahlon.
Visit SRF's LinkedIn page
Latest posts by Sichenzia Ross Ference LLP (see all)
- Attorneys Selected for Inclusion on 2019 Super Lawyers Lists - October 16, 2019
- Sichenzia Ross Ference LLP to Join Client Relmada Therapeutics, Inc. at Nasdaq Opening Bell Ringing - October 15, 2019
- Sichenzia Ross Ference LLP Congratulates Relmada Therapeutics, Inc., on NASDAQ Uplisting - October 10, 2019